Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Tamara Murdock, global head of early phase at Emerald Clinical Trials emphasises the importance for sponsors in choosing the ...

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

As launches grow more complex, softgels can help developers overcome challenges during early clinical development.

Comprehensive CNS-Focused Services The center provides end-to-end support including CNS-specific protocol design, regulatory ...

Agios Pharmaceuticals (($AGIO)) announced an update on their ongoing clinical study. Agios Pharmaceuticals has initiated a Phase 1 clinical trial ...

In the VALOR trial, brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared ...

CARLSBAD, Calif., Sept. 7, 2023 /PRNewswire/ -- Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical ...

NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class pharmacology ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the findings of new research by the Tufts Center for the Study of Drug Development ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial intelligence platform to transform oncology drug discovery and development, ...